アジェンダ
9:00 AM — 9:10 AM
9:10 AM — 9:30 AM
Key Note9:30 AM — 10:30 AM
Session 1: Regulatory Outlook for Europe10:30 AM — 11:00 AM
11:00 AM — 12:30 PM
Session 2: Regulatory Outlook for Other Regions12:30 PM — 1:30 PM
3:00 PM — 3:30 PM
9:00 AM — 9:20 AM
Numeracy and the Understanding of Clinical Trials with Biosimilars9:30 AM — 11:30 AM
Session 5: Pharmacovigilance11:30 AM — 12:00 PM
12:00 PM — 1:30 PM
Session 5: Pharmacovigilance continued1:30 PM — 2:30 PM